Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial
Authors
Keywords
Pioglitazone, Type 2 diabetes mellitus, Adiponectin, Cardiac function, Percutaneous coronary intervention
Journal
HEART AND VESSELS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-02-27
DOI
10.1007/s00380-018-1143-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
- (2017) Hung-Wei Liao et al. BMJ Open
- Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis
- (2016) Nuo Li et al. BMC Cardiovascular Disorders
- Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis
- (2016) Dina M. Khodeer et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Insulin Resistance as a Predictor of the Late Catch-up Phenomenon After Drug-Eluting Stent Implantation
- (2016) Takaaki Komatsu et al. CIRCULATION JOURNAL
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis
- (2016) Shi-jie Zhao et al. PLoS One
- Pioglitazone for Secondary Stroke Prevention
- (2016) Meng Lee et al. STROKE
- Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways
- (2016) Tetsuya Kubota et al. Scientific Reports
- Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
- (2016) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
- (2016) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Pioglitazone Increases Circulating MicroRNA-24 With Decrease in Coronary Neointimal Hyperplasia in Type 2 Diabetic Patients – Optical Coherence Tomography Analysis –
- (2015) Soon Jun Hong et al. CIRCULATION JOURNAL
- Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up
- (2015) Liang-Ping Zhao et al. CORONARY ARTERY DISEASE
- Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36)
- (2015) H Yokoyama et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Everolimus-Eluting Xience V/Promus Versus Zotarolimus-Eluting Resolute Stents in Patients With Diabetes Mellitus
- (2014) Kyung Woo Park et al. JACC-Cardiovascular Interventions
- Risk of Stroke with Thiazolidinediones: A Ten-Year Nationwide Population-Based Cohort Study
- (2013) Chien-Jung Lu et al. CEREBROVASCULAR DISEASES
- Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography
- (2013) Salvatore Cassese et al. HEART
- Pioglitazone Decreases Coronary Artery Inflammation in Impaired Glucose Tolerance and Diabetes Mellitus
- (2013) Yoshikazu Nitta et al. JACC-Cardiovascular Imaging
- Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors
- (2012) Aramesh Saremi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pioglitazone ameliorates systolic and diastolic cardiac dysfunction in rat model of angiotensin II-induced hypertension
- (2012) Aiko Sakamoto et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Impact of Insulin Resistance on Post-Procedural Myocardial Injury and Clinical Outcomes in Patients Who Underwent Elective Coronary Interventions With Drug-Eluting Stents
- (2012) Tadayuki Uetani et al. JACC-Cardiovascular Interventions
- Comparison of Three-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation Among Insulin-Treated Diabetic, Non–Insulin-Treated Diabetic, and Non-Diabetic Patients from j-Cypher Registry
- (2011) Tomohisa Tada et al. AMERICAN JOURNAL OF CARDIOLOGY
- Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus
- (2011) Adrian V. Hernandez et al. American Journal of Cardiovascular Drugs
- Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner
- (2011) Yochai Birnbaum et al. BASIC RESEARCH IN CARDIOLOGY
- Role of Pioglitazone in the Prevention of Restenosis and Need for Revascularization After Bare-Metal Stent Implantation
- (2011) Dhavalkumar Patel et al. JACC-Cardiovascular Interventions
- Pioglitazone Reduces Atherogenic Outcomes in Type 2 Diabetic Patients
- (2011) Masahiko Igarashi et al. Journal of Atherosclerosis and Thrombosis
- Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes
- (2011) Akihiro Kudoh et al. LIFE SCIENCES
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Cellular and Molecular Changes Associated With Inhibitory Effect of Pioglitazone on Neointimal Growth in Patients With Type 2 Diabetes After Zotarolimus-Eluting Stent Implantation
- (2010) Soon Jun Hong et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages
- (2009) Paska A. Permana et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial
- (2009) D. K. Coletta et al. DIABETOLOGIA
- A Prospective, Multicenter, Randomized Trial to Assess Efficacy of Pioglitazone on In-Stent Neointimal Suppression in Type 2 Diabetes
- (2009) Tsutomu Takagi et al. JACC-Cardiovascular Interventions
- Improved cardiac function after sirolimus-eluting stent placement in diabetic patients by pioglitazone: Combination therapy with statin
- (2009) Takuya Ozawa et al. Journal of Cardiology
- Effect of pioglitazone on left ventricular diastolic function and fibrosis of type III collagen in type 2 diabetic patients
- (2009) Gen Terui et al. Journal of Cardiology
- Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: A randomized prospective study using intravascular ultrasound
- (2008) Takashi Nakayama et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3′-kinase
- (2008) Rocio I. Pereira et al. LIFE SCIENCES
- Thiazolidinediones: effects on insulin resistance and the cardiovascular system
- (2007) C E Quinn et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started